Byfavo
Drug
Acacia Pharma Inc
Total Payments
$13,700
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $13,700 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $13,700 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures | Acacia Pharma Inc | $13,700 | 0 |
Top Doctors Receiving Payments for Byfavo
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Minneapolis, MN | $13,700 | 1 |
Ad
Manufacturing Companies
- Acacia Pharma Inc $13,700
Product Information
- Type Drug
- Total Payments $13,700
- Total Doctors 0
- Transactions 1
About Byfavo
Byfavo is a drug associated with $13,700 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Acacia Pharma Inc.
Payment data is available from 2021 to 2021. In 2021, $13,700 was paid across 1 transactions to 0 doctors.
The most common payment nature for Byfavo is "Unspecified" ($13,700, 100.0% of total).
Byfavo is associated with 1 research study, including "Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures" ($13,700).